Prostate Cancer Procedures

Biden Has Completed Radiation for Cancer

Joe Biden completes radiation treatment for aggressive prostate cancer: ‘Rung the bell!’

Former President Joe Biden finished a weekslong course of radiation therapy Monday for Stage 4 prostate cancer that has spread to his bones.

· 16h · on MSN

Biden 'rang the bell' after completing radiation therapy for prostate cancer

· 1d · on MSN

Biden completes round of radiation therapy to treat aggressive prostate cancer

· 12h

Joe Biden Rings the Bell After Completing Cancer Treatment

Former president Joe Biden marked the end of a major round of cancer treatment, ringing a bell after completing weeks of radiation therapy for an aggressive form of prostate cancer.

· 10h

Joe Biden completes round of radiation therapy for prostate cancer

· 15h

Joe Biden Rings The Bell After Completing Radiation Therapy Course For Prostate Cancer

CURE

Active Surveillance or Treatment? Your Guide to Stage 1 Prostate Cancer Options

This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is limited, the prognosis for stage 1 prostate cancer is generally excellent. The two main factors used to classify your cancer are:

Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue,

Morningstar

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in ...

Nasdaq

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three ...